Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | norepinephrine transporter | 0.0821 | 1 | 1 |
Loa Loa (eye worm) | serotonin transporter b | 0.0821 | 1 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0316 | 0 | 0.5 |
Leishmania major | carbonic anhydrase-like protein | 0.0316 | 0 | 0.5 |
Echinococcus multilocularis | serotonin transporter | 0.0821 | 1 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.0316 | 0 | 0.5 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0821 | 1 | 1 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0821 | 1 | 1 |
Onchocerca volvulus | 0.0821 | 1 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0821 | 1 | 1 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0821 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0821 | 1 | 1 |
Echinococcus granulosus | serotonin transporter | 0.0821 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0821 | 1 | 1 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.0316 | 0 | 0.5 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0821 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 23.1093 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.